101 Munson Street,
Greenfield , MA, 01301-9668
Greenfield , MA, 01301-9668
Summary
The fund seeks capital appreciation in the long term by investing in companies across any size in the United States.
The sub-advisor’s investment process is designed to highlight stocks of health sciences-related companies.
The investment team considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or lif More
Link
Directors
Sep 12, 2023- Sarah E. Cogan
- Brian T. Zino
- Sidney E. Harris
- R. Keith Walton
- John R. Mallin
- Deborah A. DeCotis
- F. Ford Drummond
- Philip R. McLoughlin
- George R. Aylward
- Connie D. McDaniel
- Geraldine M. McNamara
- Donald C. Burke
Chief Compliance Officer
- Timothy Branigan
Fund Manager(s)
- Peter Pirsch
- Christopher Chin
Price
- 52-Week High/Low
- $31.44 - $24.78
- Turnover
- 102%
- Expense Ratio
- 1.39%
Company Name |
Holding |
| Eli Lilly & Co | 13.27 % |
| UnitedHealth Group Inc | 4.84 % |
| AbbVie Inc | 4.81 % |
| Vertex Pharmaceuticals Inc | 4.28 % |
| Merck & Co Inc | 4.27 % |
| Edwards Lifesciences Corp | 4.06 % |
| McKesson Corp | 4.05 % |
| Cooper Cos Inc/The | 4.01 % |
| IDEXX Laboratories Inc | 3.89 % |
| Danaher Corp | 3.81 % |
| More | 3.81 % |
Advisor
Documents
Performance
YTD
-
3 Year
-28.98%
5 Year
-11.6%
Best
30.63%
2009
Worst
-26.43%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 9.8% | 0.1% | -4.2% | 3.3% | -11.9% | 9.7% | 0.5% | 9.8% | -11.6% |
| Q2 | - | -5.2% | 1.3% | -8.8% | 10.2% | 15% | 2.9% | 6.7% | 6.3% | 6.7% |
| Q3 | - | - | -6% | -9.4% | -15.7% | -8.9% | -4.2% | 10.5% | 2.4% | 2.2% |
| Q4 | - | - | 8% | 1.8% | 6.7% | 7.3% | 8.9% | -10.4% | -2.7% | -4.7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 2% | 4.5% | 3% | -3.5% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 7% | 3% | -19% | 2% | -1% | 0% | 4% | 17% | -8% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| RAGHX | - | 7% | 3% | -19% | 2% | -1% | - | 4% | 17% | -8% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 7% | 3% | 2% | -24% | -17% | - | 11% | -2% | -18% |